Search Orphan Drug Designations and Approvals
-
Generic Name: | Synthetic human secretin |
---|---|
Date Designated: | 09/18/2006 |
Orphan Designation: | For use in conjunction with diagnostic procedures (excluding ERCP) for pancreatic disorders to increase pancreatic fluid secretion |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Innovate Biopharmaceuticals, Inc. 8601 Six Forks Road Suite 400 Raleigh, North Carolina 27615 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-